Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The SURMOUNT-4 trial demonstrated that participants who discontinued tirzepatide after initial weight loss regained significant weight (approximately 14% regain over 52 weeks following randomized withdrawal), while those continuing treatment maintained their weight loss, confirming ongoing medication efficacy
It's very clear that a lot of them are contaminated with things that both in the short term, but especially in the long term can be problematic
Skip your next scheduled dose if advised
CONTRAINDICATIONS According to the package insert, Mounjaro and Zepbound is contraindicated in patients with the following: personal or family history of Medullary Thyroid Carcinoma patients with Multiple Endocrine Neoplasm type 2 patients with a prior serious hypersensitivity reaction to tirzepatide or to any of the excipients in Mounjaroand Zepbound
US$ 25.65
US$ 23.55
US$ 22.66
)
